{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-212534","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2021-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.524594+00:00","generated_at":"2026-06-30T06:04:26.863451+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Tempest Therapeutics appoints Nicholas Maestas as VP, Strategy and Finance and PFO","bullets":["Appointed Nicholas Maestas, age 41, as VP, Strategy and Finance and principal financial officer, effective July 12, 2021.","Maestas previously served as head of FP&A and strategic finance at Alector, Inc. since 2019.","Base salary of $325,000; eligible for annual performance bonus with target of 30% of base salary.","Granted option to purchase 23,225 common shares at July 12 closing price; vests 25% at 1 year, then monthly over 48 months.","Severance: 3 months salary/benefits outside change of control; 6 months salary plus 50% bonus and accelerated vesting during change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-212534","json":"https://secwatch.observer/filing/0001193125-21-212534.json","markdown":"https://secwatch.observer/filing/0001193125-21-212534.md","text":"https://secwatch.observer/filing/0001193125-21-212534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/0001193125-21-212534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/d181625d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:04:26.863451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a04b7d8e22","claim":"Nicholas Maestas was appointed as vice president, strategy and finance and principal financial officer at Tempest Therapeutics, Inc..","evidence_excerpt":"On July 12, 2021, Nicholas Maestas, age 41, joined Tempest Therapeutics, Inc. (the “Company”) as vice president, strategy and finance and is the Company’s principal financial officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312521212534/0001193125-21-212534-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"vice president, strategy and finance and principal financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}